Digital autism provider AnswersNow has successfully closed its $11 million Series A funding round, signaling a major step forward in expanding access to digital autism therapy. Based in Richmond, Virginia, the startup plans to use the funding to enter new states, grow its team of PhD- and master’s-level clinicians, and enhance its virtual platform, making it easier for families to access high-quality care.
This funding comes amid rising autism rates and increased demand for services. According to the CDC, approximately 1 in 44 children are diagnosed with autism spectrum disorder (ASD). As families seek evidence-based therapies, digital autism therapy has emerged as a critical tool for delivering personalized, convenient, and effective care.
ABA Therapy: The Gold Standard
Applied Behavior Analysis (ABA) therapy, the core service provided through digital autism therapy platforms like AnswersNow, is the gold standard for treating autism. ABA focuses on improving specific behaviors, developing communication and social skills, and supporting adaptive learning. Despite its proven benefits, access remains limited due to the shortage of board-certified behavioral analysts (BCBAs), with only 58,345 professionals nationwide.
“One of the most significant pain points for families of individuals with autism, ADHD, and other developmental disabilities is access to quality care. AnswersNow is changing that with our approach and our virtual platform,” said Jeff Beck, CEO and co-founder of AnswersNow. “This funding enables us to bring digital autism therapy to families who have long been on waitlists or live in areas without certified clinicians.”
How AnswersNow is Transforming Access
Launched in 2017, AnswersNow matches families with clinicians for virtual ABA therapy, making digital autism therapy more accessible regardless of location. Families can now receive sessions from home, avoiding long waitlists or the need to travel for care. The platform also includes real-time progress tracking, intuitive scheduling, and personalized clinician support, which improves outcomes and keeps families engaged in therapy.
The company has established partnerships with major payers, including Medicaid, UnitedHealthcare, Aetna, Cigna, Anthem, and Blue Cross Blue Shield, ensuring therapy is both accessible and affordable.
Series A Funding and Investor Support
The $11 million Series A funding round was led by Left Lane Capital, with participation from American Family Institute for Social Impact, Blue Heron Capital, Difference Partners, and former Kadiant CEO Lani Fritts. With this funding, AnswersNow can expand its clinician network, improve its virtual platform, and bring high-quality digital autism therapy to more families across the country.
Challenges in the ABA Market
Despite strong demand, ABA providers faced significant challenges in 2022. Several venture-backed digital companies, including Elemy, had to implement layoffs and adjust their business models. Traditional ABA providers, such as The Centers for Autism and Related Disorders (CARD) and 360 Behavioral Health, also reduced operations due to reimbursement limitations and labor shortages.
Many providers initially expanded rapidly to capture market share and negotiate better payer rates. However, economic realities forced some companies to scale back operations, underscoring the need for sustainable growth and innovative care delivery models like digital autism therapy.
Ongoing Venture Interest
Investor interest in autism services remains strong. Soar Health raised $16 million in equity funding, while Brightline secured an additional $10 million, bringing total funding to nearly $220 million. These investments reflect confidence in digital autism therapy and virtual behavioral health solutions as essential tools for families.
Why AnswersNow’s Model Matters
AnswersNow’s approach addresses the critical gaps in autism care. By combining technology, a network of experienced clinicians, and strong payer partnerships, the company delivers digital autism therapy that is accessible, scalable, and family-centered. Families no longer face months-long waitlists or limited local resources, and children receive consistent, evidence-based interventions.
Furthermore, the platform’s focus on tracking progress, personalized scheduling, and interactive therapy sessions enhances the effectiveness of digital autism therapy, empowering caregivers to actively participate and reinforcing positive outcomes.
Looking Ahead
With its Series A funding, AnswersNow is poised to expand nationally, grow its clinician team, and refine its virtual platform. As demand for autism services continues to rise, digital autism therapy is positioned to bridge the access gap, providing families with high-quality, flexible, and evidence-based care.
By combining technology, clinical expertise, and strong payer support, AnswersNow is helping children with autism reach their full potential while making digital autism therapy more equitable and accessible than ever before. This is a transformative moment for families and clinicians alike, highlighting the future of autism care in the digital age.
